Optical cervical cancer screening device is more accurate than standard procedures.
March 18 2006 12:00 AM EST
March 17 2006 2:23 AM EST
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Optical cervical cancer screening device is more accurate than standard procedures.
The Food and Drug Administration on Thursday approved the Luma Cervical Imaging System, an optical device used to screen for early signs of cervical cancer. The device is more accurate at identifying precancerous lesions on a woman's cervix than traditional colposcopy procedures, according to studies, allowing doctors to catch the earliest signs of the disease. The device is made by Lexington, Mass.-based MediSpectra.
Virtually all cases of cervical cancer are linked to certain strains of the sexually transmitted human papillomavirus. The FDA is currently reviewing an HPV vaccine called Gardasil, made by Merck, which could protect against several HPV strains and prevent more than 70% of cervical cancer cases. A decision by the agency on the vaccine is expected by the summer. Cervical cancer is an AIDS-defining condition among HIV-positive women. (The Advocate)
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.
WATCH & LIVESTREAM ON ADVOCATECHANNEL.COM
AND ON THE ADVOCATE CHANNEL APP
Download the Advocate Channel App for your mobile phone and your favorite streaming device!